About UsProductsInvestor RelationsPress ReleasesContact Us
May 11, 2016

Merus Labs Reports Fiscal Q2 2016 Results
March 30, 2016

Merus Announces Re-Election of Directors
March 7, 2016

Merus Completes Acquisition of Surgestone®, Provames®, Tredemine® and Speciafoldine® Rights from Sanofi
March 1, 2016

Merus Labs International Inc. Announces Closing of $27 Million Bought Deal Financing
Investor Presentation
Acquisition: UCB Products
Acquisition: Sanofi Products

Symbol: MSLI
Last:
Change:
Date:
Time:
Symbol: MSL
Last:
Change:
Date:
Time:
Quotes are delayed at least 15 minutes.

Copyright © 2016 Merus Labs Inc. All Rights Reserved.